Orthopedic Surgery Doctors in London, KY Accepting Medicare

6 Orthopedic Surgery doctors found. Showing 1 - 6

Dr. Adam Kimball Franson, D.O. Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 160 London Mountain View Dr, London, KY 40741 Phone: 606-864-0770    Fax: 606-864-1461

Dr. Vincent Angelo Depalma, D.O. Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 160 London Mountain View Dr, London, KY 40741 Phone: 606-864-0770    Fax: 606-864-1461

Jean Maurice Page', M.D. Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 160 London Mountain View Dr, London, KY 40741 Phone: 606-864-0770    Fax: 606-864-1461

Alan S Oster, M.D. Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 160 London Mountain View Dr, London, KY 40741 Phone: 606-864-0770    Fax: 606-864-1461

Patrice Beliveau, M.D. Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 160 London Mountain View Dr, London, KY 40741 Phone: 606-864-0770    Fax: 606-864-1461

Kevin Michael Magone, MD Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 160 London Mountain View Dr, London, KY 40741 Phone: 606-864-0770    Fax: 606-864-1461

News Archive

Perinatal exposure of rats to flame retardants changes the liver epigenome

Studies have shown that perinatal exposure of rats and mice to common flame retardants found in household items permanently reprograms liver metabolism, often leading later in life to insulin resistance and non-alcoholic fatty liver disease.

Inhibikase Therapeutics receives Phase II SBIR grant to advance novel RAMP medicinal chemistry program

Inhibikase Therapeutics, Inc. announces the receipt of a Phase II SBIR grant in the amount of $1.54 million dollars from the U.S. National Institutes of Health to advance its novel Re-engineering with Metabolism Preserved (RAMP) medicinal chemistry program.

New driver of atherosclerosis may prove to be promising therapeutic target

A new driver of atherosclerosis has been identified by researchers at UT Southwestern Medical Center. This molecule, known as 27HC (27-hydroxycholesterol), has been found to exacerbate the development of the condition, and may prove to be a promising therapeutic target.

CDC releases revised H1N1 estimates

USA Today: As expected, CDC released revised H1N1 estimates Thursday indicating that 3,900 people in the U.S. have died from the infection, including 540 children (Sternberg, 11/12).

New understanding of Ebola virus and tetherin protein

Researchers at the University of Pennsylvania School of Medicine have likely found one reason why the Ebola virus is such a powerful, deadly, and effective virus.

Read more Medical News

› Verified 5 days ago